Midazolam: an essential palliative care drug
E Prommer - Palliative care and social practice, 2020 - journals.sagepub.com
Midazolam is a commonly used benzodiazepine in palliative care and is considered one of
the four essential drugs needed for the promotion of quality care in dying patients. Acting on …
the four essential drugs needed for the promotion of quality care in dying patients. Acting on …
Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU
Objective: To update and expand the 2013 Clinical Practice Guidelines for the Management
of Pain, Agitation, and Delirium in Adult Patients in the ICU. Design:
of Pain, Agitation, and Delirium in Adult Patients in the ICU. Design:
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults
AL Dzierba, JL Stollings… - … : The Journal of Human …, 2023 - Wiley Online Library
Precision medicine is a growing field in critical care. Research increasingly demonstrated
pharmacogenomic variability to be an important determinant of analgesic and sedative drug …
pharmacogenomic variability to be an important determinant of analgesic and sedative drug …
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease
R Cacabelos - Expert Opinion on Drug Metabolism & Toxicology, 2020 - Taylor & Francis
Introduction Cholinergic dysfunction, demonstrated in the late 1970s and early 1980s, led to
the introduction of acetylcholinesterase inhibitors (AChEIs) in 1993 (Tacrine) to enhance …
the introduction of acetylcholinesterase inhibitors (AChEIs) in 1993 (Tacrine) to enhance …
[HTML][HTML] The coming era of precision medicine for intensive care
JL Vincent - Critical Care, 2017 - Springer
Recent advances in technology and better understanding of mechanisms underlying
disease are beginning to enable us to better characterize critically ill patients. Instead of …
disease are beginning to enable us to better characterize critically ill patients. Instead of …
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
CE Silvado, VC Terra… - Pharmacogenomics and …, 2018 - Taylor & Francis
Phenytoin (PHT) is an antiepileptic drug widely used in the treatment of focal epilepsy and
status epilepticus, and effective in controlling focal seizures with and without tonic–clonic …
status epilepticus, and effective in controlling focal seizures with and without tonic–clonic …
The pharmacogenetics of medications used in general anesthesia
S Xie, W Ma, Q Guo, J Liu, W Li, HL McLeod… - …, 2018 - Taylor & Francis
General anesthesia is a state of unconsciousness, amnesia, analgesia and akinesia
induced by drugs including opioids, hypnotic-sedative agents, muscle relaxants and …
induced by drugs including opioids, hypnotic-sedative agents, muscle relaxants and …
Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists
A Edris, A Vanoverschelde, P Bushaj… - The …, 2021 - nature.com
Over the past decade, pharmacogenetics (PGx) became an essential tool for personalized
medicine although its clinical implementation is still limited. We aimed to assess the current …
medicine although its clinical implementation is still limited. We aimed to assess the current …
[HTML][HTML] Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock
C Scorcella, R Domizi, S Amoroso, A Carsetti… - BMC …, 2023 - Springer
Background Pharmacogenetics could represent a further resource to understand the
interindividual heterogeneity of response of the host to sepsis and to provide a personalized …
interindividual heterogeneity of response of the host to sepsis and to provide a personalized …
Using l‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis
TS Jennaro, MA Puskarich, MR McCann… - … : The Journal of …, 2020 - Wiley Online Library
Objective The objective of this review is to discuss the therapeutic use and differential
treatment response to Levo‐carnitine (l‐carnitine) treatment in septic shock, and to …
treatment response to Levo‐carnitine (l‐carnitine) treatment in septic shock, and to …